Categories Uncategorized

Fibromyalgia and the Future of Telehealth

Fibromyalgia is an acute illness that can present as cognitive dysfunction, lack of energy, intense fatigue and abnormal pain among other symptoms. Sometimes, individuals who suffer from this condition may experience flares, when their symptoms get too intense. This makes it harder for them to perform simple tasks, even struggling to make it to doctor’s appointments. However, the coronavirus pandemic and improvements in technology have made it possible for fibromyalgia patients to access telehealth appointments, which allows them to talk with their doctor remotely, either via tablet, phone or computer, while they’re home.

Patients can now schedule telehealth appointments with their nurse practitioners, doctors and other healthcare providers, which eliminates the need to spend energy and time getting ready for an appointment and commuting to a physician’s office. It should be noted that telehealth is suitable for situations when a patient will be having discussions with their healthcare provider  but not physical examinations.

Patients can use telehealth to:

  • Review test results with your physician
  • Get prescription refills
  • Report any nonemergent side effects
  • Discuss treatment or medication follow-ups

Individuals should also keep in mind that some medications that are prescribed for fibromyalgia, such as tricyclic antidepressants, may require physical exams because they are known to cause severe side effects including high blood pressure.

Additionally, patients will need to schedule an in-person appointment with their physicians if:

  • They require immediate care for any serious symptoms or side effects
  • Their vital signs require monitoring
  • They need lab work
  • They’ve noticed new symptoms that need to be examined physically

When preparing for a telehealth appointment with a physician, patients should write down the questions they want to ask in order to ensure that they don’t forget. They should also record any new symptoms they’ve noticed, along with the severity of those symptoms and the effectiveness of any treatments prescribed.

Furthermore, when scheduling the telehealth appointment, patients should ask about:

  • The length of the appointment
  • Who they will be talking to — a physician’s assistant, nurse or doctor
  • Whether insurance will cover the appointment
  • Whether the appointment will include video and audio or audio alone
  • Whether they will need to provide information about blood pressure, weight, etc.

Telehealth appointments not only alleviate the strain of having in-person visits but also protect patients from contracting diseases that can aggravate fibromyalgia or bring about flares in the long term. In addition to this, telehealth appointments seem to be a solid trend, with a 2020 survey finding that more than 80% of individuals had a higher chance of choosing healthcare providers who provided telehealth appointments.

With companies such as Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) focused on developing psilocybin-based therapeutics for fibromyalgia, it won’t be long before patients may have access to an alternative to existing remedies.

NOTE TO INVESTORS: The latest news and updates relating to Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) available in the company’s newsroom at https://ibn.fm/TRYPF

About BioMedWire

BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.

To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.biomedwire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.biomedwire.com
415.949.5050 Office
Editor@BioMedWire.com

BioMedWire is part of the InvestorBrandNetwork.

Chris@BMW

Share
Published by
Chris@BMW

Recent Posts

Liquid Biopsy Forecasts Response to Immunotherapy in Lung Cancer Patients

While immunotherapy is revolutionizing cancer therapy, response rates to these novel treatments are low and some patients…

17 hours ago

Surgeon, Payer, Patient Win: The Economic and Workflow Advantages Positioning GelrinC as a New Standard of Care for Knee Cartilage Repair

Regentis recently received European regulatory approval for a next-generation GelrinC manufacturing process that increases production…

1 day ago

VERAXA Biotech AG (NASDAQ: VRXA) Advances VXA-222 Cancer Program While Expanding Patent Portfolio for Next-Generation Antibody Technologies 

The company has advanced its VXA-222 bispecific antibody-drug conjugate (“bsADC”) program into the next stage…

2 days ago

As Cases of Measles Rise, US Officials Double Down on Contact Tracing and Vaccination

As July came to an end, the United States reached an undesirable milestone: exceeding the…

3 days ago

Climate Change is Accelerating the Spread of Infectious Diseases, Experts Warn

Scientists and public health experts are warning that climate change is accelerating the rate at which infectious…

7 days ago

Novel Vitamin B12 Treatment Offers Hope in Brain Cancer Treatment

Glioblastoma multiforme (GBM) is the deadliest type of brain cancer and patients usually die within 15 months…

1 week ago